|
| Status |
Public on May 14, 2023 |
| Title |
Mechanistic study of Wee1 kinase inhibition with AZD1775 exposes drug targetable vulnerabilities in acute B-lymphoblastic leukemia [scATAC-seq] |
| Organism |
Homo sapiens |
| Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
This study characterized the effect of WEE1 kinase inhibition using AZD1775 treatment on single-cell accessible chromatin and gene expression profile in the acute lymphoblastic leukemia cell line RS4;11 that represents the KMT2A-rearranged subtype.
|
| |
|
| Overall design |
scATAC-seq samples were generated from 24 h after AZD1775 (Wee1i) using the 10x Genomics Chromium platform and protocols. DMSO treated cells were used as controls. Parallel cell cultures were processed for scRNA-seq.
|
| |
|
| Contributor(s) |
Lahnalampi M, Heinäniemi M, Malyukova A, Sangfelt O |
| Citation(s) |
38822412 |
| |
| Submission date |
Nov 25, 2022 |
| Last update date |
Jun 26, 2024 |
| Contact name |
Merja Heinäniemi |
| E-mail(s) |
merja.heinaniemi@uef.fi
|
| Organization name |
University of Eastern Finland
|
| Department |
School of Medicine, Institute of Biomedicine
|
| Lab |
Systems Genomics - Heinäniemi lab
|
| Street address |
Yliopistonranta 1E
|
| City |
Kuopio |
| ZIP/Postal code |
70211 |
| Country |
Finland |
| |
|
| Platforms (1) |
| GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
| Samples (2) |
|
| This SubSeries is part of SuperSeries: |
| GSE220114 |
Mechanistic study of Wee1 kinase inhibition with AZD1775 exposes drug targetable vulnerabilities in acute B-lymphoblastic leukemia |
|
| Relations |
| BioProject |
PRJNA905534 |
